SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-09-004133
Filing Date
2009-04-14
Accepted
2009-04-14 16:35:26
Documents
3
Period of Report
2009-05-19
Effectiveness Date
2009-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2192158zdef14a.htm DEF 14A 621226
2 G377234.JPG g377234.jpg GRAPHIC 11694
3 G5368.JPG g5368.jpg GRAPHIC 34157
  Complete submission text file 0001047469-09-004133.txt   686215
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 09749013
SIC: 2834 Pharmaceutical Preparations